CDX2 Monoclonal Antibody

Code CSB-MA437110
Size US$384
Order now
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Alternative Names
Caudal type homeo box 2; Caudal type homeo box transcription factor 2; Caudal type homeobox 2; Caudal type homeobox protein 2; caudal type homeobox transcription factor 2; Caudal-type homeobox protein 2; CDX 2; CDX 3; CDX-3; Cdx2; CDX2_HUMAN; CDX3;
Raised in
Mouse
Species Reactivity
Human,Monkey,Mouse
Immunogen
Purified recombinant Human CDX2 protein fragments expressed in E.coli
Immunogen Species
Homo sapiens (Human)
Clonality
Monoclonal
Isotype
lgG2b
Clone No.
4B9-B12-E9
Purification Method
Affinity purified
Concentration
It differs from different batches. Please contact us to confirm it.
Form
Purified mouse monoclonal in PBS(pH 7.4)containing with 0.2% sodium azide,50% glycerol.
Tested Applications
ELISA,WB,ICC,IP
Recommended Dilution
Application Recommended Dilution
WB 1:500-1:5000
ICC 1:50-1:200IP:1:200-1:2000
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
webinars: DT3C facilitates antibody internalization X
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*